* Download comes with a free subscription to our newsletter. You can unsubscribe any time. You will not get duplicate emails if you download more than one report.

  1. 1

From the publication:

The aim of this study was to investigate the expression of MFSD2a in the whole blood and brain as a potential biomarker of Alzheimer’s disease (AD). […] We found a significant and progressive decline of MFSD2a levels in blood of AD patients. We also corroborated a significant reduction of DHA and other n-3 long-chain polyunsaturated FA in serum of AD.

  1. You must first login , or register before you can comment.

    Markdown formatting available